Bal Pharma Other Announcement

Bal Pharma Q2 FY27 Results: Net Profit ₹1.4 Cr, Up 100.0% YoY

Bal Pharma Ltd reported revenue from operations of ₹89.9 Cr (+21.5% YoY) and net profit of ₹1.4 Cr (+100.0% YoY) for Q2 FY27.

Key figure

Net profit ₹1.4 Cr · +100.0% YoY

Bal Pharma Board Meeting Date

Bal Pharma Limited informs exchanges of a board meeting on November 11, 2026, to consider unaudited standalone and consolidated results for Q2 FY2026-27. This is a prior intimation with no results figures attached yet.

Bal Pharma Other Announcement

Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.

Bal Pharma Dividend

Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.

Bal Pharma Management Change

Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.

Bal Pharma Annual General Meeting

Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.

Glottis Other Announcement

Glottis Limited filed its Reg 32 statement confirming no deviation in IPO fund utilisation for the quarter ended September 30, 2026. Gross proceeds of ₹15,999.87 Lakhs were raised, with ₹9,009.54 Lakhs utilised so far.

Lenskart Solutions Other Announcement

Lenskart filed a Reg 32 monitoring agency report on IPO proceeds for the quarter ended September 2026. Utilisation matches the prospectus with no deviations.

TGV SRAAC Other Announcement

TGV Sraac's board noted a CIN change, registered by MCA on 27 October 2026. It followed an objects clause alteration approved at the September 2026 AGM.

Manaksia Coated Metals & Industries Other Announcement

Manaksia Coated Metals filed its quarterly shareholding pattern, with promoters holding 51.93%. The filing is routine regulatory disclosure with no transaction or corporate event.

Network People Services Technologies Other Announcement

Network People Services Technologies reported a Reg 32 statement confirming no deviation in use of its Rs 300 Crore preferential allotment proceeds. Rs 56.52 Crore utilised by September 30, 2026, with the Audit Committee reviewing it.

Tata Power Company Other Announcement

Tata Power's auditor SRBC & Co issued a limited-assurance report confirming compliance with debenture trust deed covenants as at September 30, 2026. It is a routine Reg 56(1)(d) compliance certificate with no new money or business event.